Research
Hormonal
Once-weekly GLP-1RA therapy can produce substantial weight loss over prolonged treatment (up to 23% at 72 weeks), alongside improvements in metabolic outcomes and reduced cardiometabolic risk.
GLP-1RA therapies can be effective for significant weight loss and improving metabolic health in obese patients.
StrongSupportsmedium confidence
Once-weekly GLP-1RA therapy can produce substantial weight loss over prolonged treatment (up to 23% at 72 weeks), alongside improvements in metabolic outcomes and reduced cardiometabolic risk.
Why this rating
The claim is based on findings from multiple studies referenced in the abstract.
Source
Body composition matters: Preserving muscle and function in the era of GLP‐1‐based weight loss therapies
Eric B. Emanuelsson et al. · The Journal of Physiology · 2025
other
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →